1. Home
  2. ITRM vs PBBK Comparison

ITRM vs PBBK Comparison

Compare ITRM & PBBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITRM
  • PBBK
  • Stock Information
  • Founded
  • ITRM 2015
  • PBBK 1919
  • Country
  • ITRM Ireland
  • PBBK United States
  • Employees
  • ITRM N/A
  • PBBK 37
  • Industry
  • ITRM Biotechnology: Pharmaceutical Preparations
  • PBBK Banks
  • Sector
  • ITRM Health Care
  • PBBK Finance
  • Exchange
  • ITRM Nasdaq
  • PBBK Nasdaq
  • Market Cap
  • ITRM 40.0M
  • PBBK 45.2M
  • IPO Year
  • ITRM 2018
  • PBBK N/A
  • Fundamental
  • Price
  • ITRM $1.01
  • PBBK $18.79
  • Analyst Decision
  • ITRM Strong Buy
  • PBBK
  • Analyst Count
  • ITRM 2
  • PBBK 0
  • Target Price
  • ITRM $7.00
  • PBBK N/A
  • AVG Volume (30 Days)
  • ITRM 481.0K
  • PBBK 4.6K
  • Earning Date
  • ITRM 08-13-2025
  • PBBK 08-13-2025
  • Dividend Yield
  • ITRM N/A
  • PBBK N/A
  • EPS Growth
  • ITRM N/A
  • PBBK 12.16
  • EPS
  • ITRM N/A
  • PBBK 0.83
  • Revenue
  • ITRM N/A
  • PBBK $12,804,000.00
  • Revenue This Year
  • ITRM N/A
  • PBBK N/A
  • Revenue Next Year
  • ITRM $270.19
  • PBBK N/A
  • P/E Ratio
  • ITRM N/A
  • PBBK $21.62
  • Revenue Growth
  • ITRM N/A
  • PBBK 5.21
  • 52 Week Low
  • ITRM $0.81
  • PBBK $13.85
  • 52 Week High
  • ITRM $3.02
  • PBBK $19.05
  • Technical
  • Relative Strength Index (RSI)
  • ITRM 51.14
  • PBBK 66.45
  • Support Level
  • ITRM $0.93
  • PBBK $16.49
  • Resistance Level
  • ITRM $1.06
  • PBBK $19.05
  • Average True Range (ATR)
  • ITRM 0.05
  • PBBK 0.59
  • MACD
  • ITRM 0.01
  • PBBK 0.14
  • Stochastic Oscillator
  • ITRM 34.78
  • PBBK 91.23

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

About PBBK PB Bankshares Inc.

PB Bankshares Inc follows a community bank model and provides multiple services to individuals and small to midsize businesses. Its business consists of attracting retail and commercial deposits from the general public in its market area and investing those deposits, together with funds generated from operations and borrowings, in commercial real estate loans, commercial and industrial loans, construction, home equity lines of credit and to a lesser extent, one- to four-family residential real estate loans and consumer loans.

Share on Social Networks: